| Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
Variable | Â | N | HR (95% CI) | p value | HR (95% CI) | p value |
Age, years | < 65 | 125 | 1 | 0.734 | – | – |
≥65 | 26 | 1.09 (0.67–1.77) |  | – | – | |
Sex | Male | 137 | 1 | 0.678 | – | – |
Female | 14 | 0.86 (0.42–1.77) |  | – | – | |
ECOG PS | 0 | 52 | 1 | 0.326 | – | – |
1–2 | 99 | 1.23 (0.82–1.84) |  | – | – | |
Etiology | HBV | 134 | 1 | 0.784 | – | – |
Non-HBV | 17 | 1.09 (0.60–1.98) |  | – | – | |
Child-Pugh class | A | 140 | 1 | 0.118 | – | – |
B | 11 | 1.73 (0.87–3.43) |  | – | – | |
BCLC stage | B | 5 | 1 | 0.383 | – | – |
C | 146 | 1.67 (0.53–5.26) |  | – | – | |
MVI | No | 88 | 1 | < 0.0001 | 1 | 0.125 |
Yes | 63 | 2.17 (1.48–3.18) |  | 1.37 (0.92–2.06) |  | |
EHS | No | 15 | 1 | 0.775 | – | – |
Yes | 136 | 1.10 (0.57–2.11) |  | – | – | |
AFP (ng/mL) | < 200 | 73 | 1 | < 0.0001 | 1 | 0.005 |
≥200 | 77 | 2.27 (1.53–3.37) |  | 1.80 (1.19–2.73) |  | |
cfDNA (ng/μL) | ≤0.71a) | 76 | 1 | < 0.0001 | 1 | < 0.0001 |
> 0.71a) | 75 | 3.50 (2.36–5.20) |  | 2.51 (1.62–3.89) |  | |
I-score | ≤1637a) | 76 | 1 | < 0.0001 | 1 | 0.010 |
>1637a) | 75 | 3.35 (2.24–5.01) |  | 1.85 (1.16–2.96) |  |